JP2023521853A5 - - Google Patents

Info

Publication number
JP2023521853A5
JP2023521853A5 JP2022562381A JP2022562381A JP2023521853A5 JP 2023521853 A5 JP2023521853 A5 JP 2023521853A5 JP 2022562381 A JP2022562381 A JP 2022562381A JP 2022562381 A JP2022562381 A JP 2022562381A JP 2023521853 A5 JP2023521853 A5 JP 2023521853A5
Authority
JP
Japan
Prior art keywords
composition
cells
use according
administered
infusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022562381A
Other languages
English (en)
Japanese (ja)
Other versions
JP7817183B2 (ja
JP2023521853A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/027152 external-priority patent/WO2021211628A1/en
Publication of JP2023521853A publication Critical patent/JP2023521853A/ja
Publication of JP2023521853A5 publication Critical patent/JP2023521853A5/ja
Priority to JP2026017547A priority Critical patent/JP2026108614A/ja
Application granted granted Critical
Publication of JP7817183B2 publication Critical patent/JP7817183B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022562381A 2020-04-14 2021-04-13 がんの治療における使用のための組成物及び方法 Active JP7817183B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026017547A JP2026108614A (ja) 2020-04-14 2026-02-05 がんの治療における使用のための組成物及び方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063009569P 2020-04-14 2020-04-14
US63/009,569 2020-04-14
PCT/US2021/027152 WO2021211628A1 (en) 2020-04-14 2021-04-13 Compositions and methods for use in the treatment of cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026017547A Division JP2026108614A (ja) 2020-04-14 2026-02-05 がんの治療における使用のための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2023521853A JP2023521853A (ja) 2023-05-25
JP2023521853A5 true JP2023521853A5 (cg-RX-API-DMAC7.html) 2024-04-23
JP7817183B2 JP7817183B2 (ja) 2026-02-18

Family

ID=75770021

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022562381A Active JP7817183B2 (ja) 2020-04-14 2021-04-13 がんの治療における使用のための組成物及び方法
JP2026017547A Pending JP2026108614A (ja) 2020-04-14 2026-02-05 がんの治療における使用のための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026017547A Pending JP2026108614A (ja) 2020-04-14 2026-02-05 がんの治療における使用のための組成物及び方法

Country Status (11)

Country Link
US (1) US20230190811A1 (cg-RX-API-DMAC7.html)
EP (1) EP4135758A1 (cg-RX-API-DMAC7.html)
JP (2) JP7817183B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230011295A (cg-RX-API-DMAC7.html)
CN (1) CN115996747A (cg-RX-API-DMAC7.html)
AU (1) AU2021255869A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022020650A2 (cg-RX-API-DMAC7.html)
CA (1) CA3174777A1 (cg-RX-API-DMAC7.html)
IL (1) IL297025A (cg-RX-API-DMAC7.html)
MX (1) MX2022012956A (cg-RX-API-DMAC7.html)
WO (1) WO2021211628A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018393110B2 (en) 2017-12-20 2023-04-27 Poseida Therapeutics, Inc. VCAR compositions and methods for use
CN117290747B (zh) * 2023-11-24 2024-03-12 中国民用航空飞行学院 基于眼动数据的飞行状态监测方法、存储介质及电子设备

Family Cites Families (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4309989A (en) 1976-02-09 1982-01-12 The Curators Of The University Of Missouri Topical application of medication by ultrasound with coupling agent
FR2374910A1 (fr) 1976-10-23 1978-07-21 Choay Sa Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
GB2097032B (en) 1981-04-22 1984-09-19 Teron International Urban Dev A combined ceiling air and services distribution system mechanical chasse and structural roof member
US4656134A (en) 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4818542A (en) 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
SE448277B (sv) 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
US4766067A (en) 1985-05-31 1988-08-23 President And Fellows Of Harvard College Gene amplification
US5618920A (en) 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US5576195A (en) 1985-11-01 1996-11-19 Xoma Corporation Vectors with pectate lyase signal sequence
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
SE453566B (sv) 1986-03-07 1988-02-15 Draco Ab Anordning vid pulverinhalatorer
US4767402A (en) 1986-07-08 1988-08-30 Massachusetts Institute Of Technology Ultrasound enhancement of transdermal drug delivery
US4925673A (en) 1986-08-18 1990-05-15 Clinical Technologies Associates, Inc. Delivery systems for pharmacological agents encapsulated with proteinoids
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4704692A (en) 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4795699A (en) 1987-01-14 1989-01-03 President And Fellows Of Harvard College T7 DNA polymerase
US4921794A (en) 1987-01-14 1990-05-01 President And Fellows Of Harvard College T7 DNA polymerase
US4939666A (en) 1987-09-02 1990-07-03 Genex Corporation Incremental macromolecule construction methods
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5142033A (en) 1988-09-23 1992-08-25 Hoffmann-La Roche Inc. Structure-independent DNA amplification by the polymerase chain reaction
US5066584A (en) 1988-09-23 1991-11-19 Cetus Corporation Methods for generating single stranded dna by the polymerase chain reaction
US5091310A (en) 1988-09-23 1992-02-25 Cetus Corporation Structure-independent dna amplification by the polymerase chain reaction
US4994370A (en) 1989-01-03 1991-02-19 The United States Of America As Represented By The Department Of Health And Human Services DNA amplification technique
US5266491A (en) 1989-03-14 1993-11-30 Mochida Pharmaceutical Co., Ltd. DNA fragment and expression plasmid containing the DNA fragment
ES2118066T3 (es) 1989-10-05 1998-09-16 Optein Inc Sintesis y aislamiento, exentos de celulas, de nuevos genes y polipeptidos.
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
ES2109945T3 (es) 1990-06-01 1998-02-01 Chiron Corp Composiciones y procedimientos para identificar moleculas biologicamente activas.
US5723286A (en) 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
US5580734A (en) 1990-07-13 1996-12-03 Transkaryotic Therapies, Inc. Method of producing a physical map contigous DNA sequences
WO1992005258A1 (en) 1990-09-20 1992-04-02 La Trobe University Gene encoding barley enzyme
DE69129154T2 (de) 1990-12-03 1998-08-20 Genentech, Inc., South San Francisco, Calif. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
IE920562A1 (en) 1991-02-21 1992-08-26 Gilead Sciences Aptamer specific for biomolecules and method of making
US5404871A (en) 1991-03-05 1995-04-11 Aradigm Delivery of aerosol medications for inspiration
AU1674292A (en) 1991-03-15 1992-10-21 Synergen, Inc. Pegylation of polypeptides
ES2141108T3 (es) 1991-07-02 2000-03-16 Inhale Inc Metodo y dispositivo para proporcionar medicamentos en aerosol.
US5270170A (en) 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5968502A (en) 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
AU4829593A (en) 1992-09-23 1994-04-12 Fisons Plc Inhalation device
DE69322789T2 (de) 1992-10-19 1999-07-01 Dura Pharmaceuticals, Inc., San Diego, Calif. Trockenpulverinhalator
US5643252A (en) 1992-10-28 1997-07-01 Venisect, Inc. Laser perforator
WO1994012520A1 (en) 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
US5849695A (en) 1993-01-13 1998-12-15 The Regents Of The University Of California Parathyroid hormone analogues useful for treatment of osteoporosis and disorders of calcium meatabolism in mammals
AU5883694A (en) 1993-01-19 1994-08-15 Glaxo Group Limited Device
HUT73101A (en) 1993-02-12 1996-06-28 Harvard College Method for regulating transcription of targeted genes and other biological events
US5514670A (en) 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
US5814599A (en) 1995-08-04 1998-09-29 Massachusetts Insitiute Of Technology Transdermal delivery of encapsulated drugs
US5763733A (en) 1994-10-13 1998-06-09 Enzon, Inc. Antigen-binding fusion proteins
US5549551A (en) 1994-12-22 1996-08-27 Advanced Cardiovascular Systems, Inc. Adjustable length balloon catheter
US5656730A (en) 1995-04-07 1997-08-12 Enzon, Inc. Stabilized monomeric protein compositions
US6019968A (en) 1995-04-14 2000-02-01 Inhale Therapeutic Systems, Inc. Dispersible antibody compositions and methods for their preparation and use
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
GB9526100D0 (en) 1995-12-20 1996-02-21 Intersurgical Ltd Nebulizer
CN1213974A (zh) 1996-01-03 1999-04-14 葛兰素集团有限公司 吸入器具
US5879681A (en) 1997-02-07 1999-03-09 Emisphere Technolgies Inc. Compounds and compositions for delivering active agents
US5921447A (en) 1997-02-13 1999-07-13 Glaxo Wellcome Inc. Flow-through metered aerosol dispensing apparatus and method of use thereof
IL120943A (en) 1997-05-29 2004-03-28 Univ Ben Gurion A system for administering drugs through the skin
ATE248583T1 (de) 1997-09-29 2003-09-15 Nektar Therapeutics In dosierinhalatoren verwendbare, stabilisierte zubereitungen
US6309663B1 (en) 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
BR112019000683A2 (pt) * 2016-07-15 2019-04-24 Poseida Therapeutics Inc receptores de antígeno quiméricos e métodos para uso
WO2018014039A1 (en) 2016-07-15 2018-01-18 Poseida Therapeutics, Inc. Chimeric antigen receptors (cars) specific for muc1 and methods for their use
AU2018393110B2 (en) * 2017-12-20 2023-04-27 Poseida Therapeutics, Inc. VCAR compositions and methods for use
BR112020018049A2 (pt) 2018-03-07 2020-12-29 Poseida Therapeutics, Inc. Composições de cartirina e métodos para uso
US12630603B2 (en) * 2020-02-20 2026-05-19 Kite Pharma, Inc. Chimeric antigen receptor T cell therapy

Similar Documents

Publication Publication Date Title
Tanaka et al. A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus
AU2021229250B2 (en) Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4r inhibitor
Robak Monoclonal antibodies in the treatment of autoimmune cytopenias
Hardinger et al. Novel immunosuppressive agents in kidney transplantation
JP2020002172A5 (cg-RX-API-DMAC7.html)
DE05075555T1 (de) Immuntherapie von Autoimmunerkrankungen durch die Verwendung von B-Zell-spezifischen Antikörpern
TW201024310A (en) Antitumor combinations containing antibodies recognizing specifically CD38 and vincristine
WO2018223923A1 (zh) Pd-1抗体与vegf配体或vegf受体抑制剂联合在制备治疗肿瘤的药物中的用途
JP2023551559A5 (cg-RX-API-DMAC7.html)
JP2023508496A5 (cg-RX-API-DMAC7.html)
CN105251004A (zh) 在诊断和治疗类风湿性关节炎中使用的包含抗-cd6单克隆抗体的药物组合物
CA2939464A1 (en) Use of anti-ccr5 antibodies in graft versus host disease
JP2015500822A5 (cg-RX-API-DMAC7.html)
JP2019532970A5 (cg-RX-API-DMAC7.html)
KR20240117655A (ko) 항-cd19 항체 및 베네토클락스 조합 치료에 대한 치료 패러다임
IL292706A (en) Type i interferon inhibition in systemic lupus erythematosus
JP2024133551A (ja) Cd47遮断療法およびcd38抗体の組み合わせ
CN109641965A (zh) 使用奥法木单抗治疗多发性硬化的方案和方法
JP2024537288A5 (cg-RX-API-DMAC7.html)
JP2025502061A5 (cg-RX-API-DMAC7.html)
CN112955148B (zh) Cdk4/6抑制剂联合免疫治疗在制备治疗淋巴瘤的药物中的用途
US20250304696A1 (en) Methods and compositions for treating barth syndrome
JP2022520572A5 (cg-RX-API-DMAC7.html)
Tang-Whitmore et al. Successful treatment of pemphigus vulgaris with obinutuzumab
JP2024505923A5 (cg-RX-API-DMAC7.html)